Financial reports
10-K
2022 FY
Annual report
27 Feb 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
31 Mar 22
10-Q
2021 Q3
Quarterly report
22 Nov 21
NT 10-Q
Notice of late quarterly filing
15 Nov 21
10-Q
2021 Q2
Quarterly report
18 Aug 21
NT 10-Q
Notice of late quarterly filing
16 Aug 21
10-Q
2021 Q1
Quarterly report
22 Jun 21
Current reports
8-K
Departure of Directors or Certain Officers
28 Feb 23
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
21 Feb 23
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
13 Feb 23
8-K
Entry into a Material Definitive Agreement
30 Jan 23
8-K
Regulation FD Disclosure
14 Dec 22
8-K
Entry into a Material Definitive Agreement
17 Oct 22
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
22 Nov 21
8-K
European Biotech Acquisition Corp. Receives Expected Notification from Nasdaq Related to Delayed Quarterly Report
4 Jun 21
8-K
Unregistered Sales of Equity Securities
7 May 21
8-K
Other Events
4 May 21
Registration and prospectus
15-12G
Securities registration termination
13 Mar 23
25-NSE/A
Exchange delisting (amended)
2 Mar 23
425
Business combination disclosure
30 Jan 23
425
Business combination disclosure
14 Dec 22
F-4
Registration of securities (foreign)
7 Nov 22
424B4
Prospectus supplement with pricing info
17 Mar 21
S-1MEF
Registration of additional securities for an S-1
15 Mar 21
S-1/A
IPO registration (amended)
15 Mar 21
8-A12B
Registration of securities on exchange
12 Mar 21
S-1/A
IPO registration (amended)
11 Mar 21
Other
UPLOAD
Letter from SEC
31 Jan 23
UPLOAD
Letter from SEC
12 Jan 23
UPLOAD
Letter from SEC
20 Dec 22
UPLOAD
Letter from SEC
2 Dec 22
EFFECT
Notice of effectiveness
16 Mar 21
CERT
Certification of approval for exchange listing
15 Mar 21
CORRESP
Correspondence with SEC
12 Mar 21
CORRESP
Correspondence with SEC
12 Mar 21
CORRESP
Correspondence with SEC
8 Mar 21
UPLOAD
Letter from SEC
5 Mar 21
Ownership
SC 13G
GLAZER CAPITAL, LLC
14 Feb 23
SC 13G
PERISCOPE CAPITAL INC.
13 Feb 23
SC 13G/A
INTEGRATED CORE STRATEGIES (US) LLC
6 Feb 23
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 22
SC 13G
LSP Sponsor EBAC B.V.
8 Feb 22
SC 13G/A
INTEGRATED CORE STRATEGIES (US) LLC
27 Jan 22
3
Mohammad Sohail Fazeli
14 May 21
SC 13G
CITADEL ADVISORS LLC
2 Apr 21
SC 13G
INTEGRATED CORE STRATEGIES (US) LLC
24 Mar 21
3
de Stolpe Onno van
15 Mar 21